Patents by Inventor Paul R. Lesch

Paul R. Lesch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11806489
    Abstract: An inflation device includes a syringe body containing a bore. The bore holds a fluid that is used to inflate a separate device such as a dilation balloon. A plunger assembly slides within the syringe bore and contains a sealing member that forms a fluid tight seal with the syringe body. A shut-off valve is disposed within the distal end of the syringe body. The distal end of the syringe body has a fluid bypass channel fluidically coupled to the aperture of a connector. The shut-off valve has a spring-biased moveable piston with a bypass lumen contained therein, wherein the bypass lumen forms a fluid path between the bore and the fluid bypass channel when the pressure of the fluid is below a threshold value. The fluid path between the bore and the fluid bypass channel is interrupted when the pressure of the fluid is above the threshold value.
    Type: Grant
    Filed: March 18, 2021
    Date of Patent: November 7, 2023
    Assignee: Entellus Medical, Inc.
    Inventors: Paul R. Lesch, Jr., Paul A. Vajgrt, Timothy B. Petrick
  • Publication number: 20230270950
    Abstract: A safety member for use with an injection device is disclosed. The safety member includes a blocking ring extending into a housing of the injection device in blocking association with a latch member associated with a trigger mechanism of the injector, in which the blocking ring blocks movement of a portion of the trigger mechanism into a firing position. The safety member further includes a manipulable portion disposed outside the housing and configured for hand-manipulation by a user to remove the safety member from the housing to unblock the firing mechanism to enable firing of the injector.
    Type: Application
    Filed: May 10, 2023
    Publication date: August 31, 2023
    Applicant: Antares Pharma, Inc.
    Inventors: Julius C. Sund, Eric Lagman, Peter A. Hoeft, Paul R. Lesch, JR., Thomas E. Kramer
  • Patent number: 11684723
    Abstract: A safety member for use with an injection device is disclosed. The safety member includes a blocking ring extending into a housing of the injection device in blocking association with a latch member associated with a trigger mechanism of the injector, in which the blocking ring blocks movement of a portion of the trigger mechanism into a firing position. The safety member further includes a manipulable portion disposed outside the housing and configured for hand-manipulation by a user to remove the safety member from the housing to unblock the firing mechanism to enable firing of the injector.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: June 27, 2023
    Assignee: Antares Pharma, Inc.
    Inventors: Julius C. Sund, Eric Lagman, Peter A. Hoeft, Paul R. Lesch, Jr., Thomas E. Kramer
  • Publication number: 20230001093
    Abstract: An injector for injecting a medicament in a patient. The injector includes a container comprising a fluid chamber containing a first volume of a medicament, and an injection conduit associated with the fluid chamber for defining a fluid pathway therefrom to inject the medicament from the fluid chamber through the injection conduit to an injection location. The injector also includes a firing mechanism associated with the fluid chamber for expelling the medicament from the fluid chamber through the injection conduit, arid a volume-control mechanism operable to control a fraction of the first volume of medicament that is injected when the firing mechanism is actuated to inject the medicament.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 5, 2023
    Applicant: Antares Pharma, Inc.
    Inventors: Paul R. LESCH, Matthew H. RUST, Thomas E. KRAMER
  • Publication number: 20220379032
    Abstract: A jet injector that includes a prefilled syringe. The syringe includes a fluid chamber that contains a medicament. The syringe also has an injection-assisting needle, and a plunger is movable within the fluid chamber. A housing is configured for allowing insertion of the needle to a penetration depth. An energy source is configured for biasing the plunger to produce an injecting pressure in the medicament in the fluid chamber of between about 80 and 1000 p.s.i. to jet inject the medicament from the fluid chamber through the needle to an injection site.
    Type: Application
    Filed: August 11, 2022
    Publication date: December 1, 2022
    Applicant: Antares Pharma, Inc.
    Inventor: Paul R. Lesch
  • Patent number: 11471600
    Abstract: An injector for injecting a medicament in a patient. The injector includes a container comprising a fluid chamber containing a first volume of a medicament, and an injection conduit associated with the fluid chamber for defining a fluid pathway therefrom to inject the medicament from the fluid chamber through the injection conduit to an injection location. The injector also includes a firing mechanism associated with the fluid chamber for expelling the medicament from the fluid chamber through the injection conduit, and a volume-control mechanism operable to control a fraction of the first volume of medicament that is injected when the firing mechanism is actuated to inject the medicament.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: October 18, 2022
    Assignee: Antares Pharma, Inc.
    Inventors: Paul R. Lesch, Matthew H. Rust, Thomas E. Kramer
  • Patent number: 11446441
    Abstract: A jet injector that includes a prefilled syringe. The syringe includes a fluid chamber that contains a medicament. The syringe also has an injection-assisting needle, and a plunger is movable within the fluid chamber. A housing is configured for allowing insertion of the needle to a penetration depth. An energy source is configured for biasing the plunger to produce an injecting pressure in the medicament in the fluid chamber of between about 80 and 1000 p.s.i. to jet inject the medicament from the fluid chamber through the needle to an injection site.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: September 20, 2022
    Assignee: ANTARES PHARMA, INC.
    Inventor: Paul R. Lesch, Jr.
  • Publication number: 20210322734
    Abstract: An inflation device includes a syringe body containing a bore. The bore holds a fluid that is used to inflate a separate device such as a dilation balloon. A plunger assembly slides within the syringe bore and contains a sealing member that forms a fluid tight seal with the syringe body. A shut-off valve is disposed within the distal end of the syringe body. The distal end of the syringe body has a fluid bypass channel fluidically coupled to the aperture of a connector. The shut-off valve has a spring-biased moveable piston with a bypass lumen contained therein, wherein the bypass lumen forms a fluid path between the bore and the fluid bypass channel when the pressure of the fluid is below a threshold value. The fluid path between the bore and the fluid bypass channel is interrupted when the pressure of the fluid is above the threshold value.
    Type: Application
    Filed: March 18, 2021
    Publication date: October 21, 2021
    Inventors: Paul R. Lesch, JR., Paul A. Vajgrt, Timothy B. Petrick
  • Patent number: 10967155
    Abstract: An inflation device includes a syringe body containing a bore. The bore holds a fluid that is used to inflate a separate device such as a dilation balloon. A plunger assembly slides within the syringe bore and contains a sealing member that forms a fluid tight seal with the syringe body. A shut-off valve is disposed within the distal end of the syringe body. The distal end of the syringe body has a fluid bypass channel fluidically coupled to the aperture of a connector. The shut-off valve has a spring-biased moveable piston with a bypass lumen contained therein, wherein the bypass lumen forms a fluid path between the bore and the fluid bypass channel when the pressure of the fluid is below a threshold value. The fluid path between the bore and the fluid bypass channel is interrupted when the pressure of the fluid is above the threshold value.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: April 6, 2021
    Assignee: Entellus Medical, Inc.
    Inventors: Paul R. Lesch, Jr., Paul A. Vajgrt, Timothy B. Petrick
  • Publication number: 20200338273
    Abstract: A safety member for use with an injection device is disclosed. The safety member includes a blocking ring extending into a housing of the injection device in blocking association with a latch member associated with a trigger mechanism of the injector, in which the blocking ring blocks movement of a portion of the trigger mechanism into a firing position. The safety member further includes a manipulable portion disposed outside the housing and configured for hand-manipulation by a user to remove the safety member from the housing to unblock the firing mechanism to enable firing of the injector.
    Type: Application
    Filed: July 10, 2020
    Publication date: October 29, 2020
    Applicant: Antares Pharma, Inc.
    Inventors: Julius C. Sund, Eric Lagman, Peter A. Hoeft, Paul R. Lesch, JR., Thomas E. Kramer
  • Patent number: 10709844
    Abstract: A safety member for use with an injection device is disclosed. The safety member includes a blocking ring extending into a housing of the injection device in blocking association with a latch member associated with a trigger mechanism of the injector, in which the blocking ring blocks movement of a portion of the trigger mechanism into a firing position. The safety member further includes a manipulable portion disposed outside the housing and configured for hand-manipulation by a user to remove the safety member from the housing to unblock the firing mechanism to enable firing of the injector.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: July 14, 2020
    Assignee: Antares Pharma, Inc.
    Inventors: Julius C. Sund, Eric Lagman, Peter A. Hoeft, Paul R. Lesch, Jr., Thomas E. Kramer
  • Patent number: 10646662
    Abstract: An injection device that comprises a chamber configured for containing a substance to be injected and a needle operatively associated with the chamber and having a length sufficient to deliver the substance to an intradermal injection site. A collar surrounds the needle, defining a collar cavity. The collar also has a peripheral forward skin-contacting surface that surrounds and is radially spaced from the needle and injection site by an area that is sufficiently large to allow a patient's skin to move into the collar cavity to properly position the needle for intradermal delivery of the substance to the injection site to allow spread of the injected substance under the skin while inhibiting or preventing backpressure within the skin from forcing the substance out through the injection site.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: May 12, 2020
    Assignee: Antares Pharma, Inc.
    Inventors: Peter L. Sadowski, Paul R. Lesch, David L. Bremseth
  • Publication number: 20200114081
    Abstract: An injector for injecting a medicament in a patient. The injector includes a container comprising a fluid chamber containing a first volume of a medicament, and an injection conduit associated with the fluid chamber for defining a fluid pathway therefrom to inject the medicament from the fluid chamber through the injection conduit to an injection location. The injector also includes a firing mechanism associated with the fluid chamber for expelling the medicament from the fluid chamber through the injection conduit, and a volume-control mechanism operable to control a fraction of the first volume of medicament that is injected when the firing mechanism is actuated to inject the medicament.
    Type: Application
    Filed: December 13, 2019
    Publication date: April 16, 2020
    Applicant: Antares Pharma, Inc.
    Inventors: Paul R. Lesch, Matthew H. RUST, Thomas E. KRAMER
  • Publication number: 20200038589
    Abstract: A jet injector that includes a prefilled syringe. The syringe includes a fluid chamber that contains a medicament. The syringe also has an injection-assisting needle, and a plunger is movable within the fluid chamber. A housing is configured for allowing insertion of the needle to a penetration depth. An energy source is configured for biasing the plunger to produce an injecting pressure in the medicament in the fluid chamber of between about 80 and 1000 p.s.i. to jet inject the medicament from the fluid chamber through the needle to an injection site.
    Type: Application
    Filed: October 11, 2019
    Publication date: February 6, 2020
    Applicant: Antares Pharma, Inc.
    Inventor: Paul R. Lesch, JR.
  • Patent number: 10543316
    Abstract: An injector for injecting a medicament in a patient. The injector includes a container comprising a fluid chamber containing a first volume of a medicament, and an injection conduit associated with the fluid chamber for defining a fluid pathway therefrom to inject the medicament from the fluid chamber through the injection conduit to an injection location. The injector also includes a firing mechanism associated with the fluid chamber for expelling the medicament from the fluid chamber through the injection conduit, and a volume-control mechanism operable to control a fraction of the first volume of medicament that is injected when the firing mechanism is actuated to inject the medicament.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: January 28, 2020
    Assignee: Antares Pharma, Inc.
    Inventors: Paul R. Lesch, Matthew H. Rust, Thomas E. Kramer
  • Patent number: 10478560
    Abstract: A jet injector that includes a prefilled syringe. The syringe includes a fluid chamber that contains a medicament. The syringe also has an injection-assisting needle, and a plunger is movable within the fluid chamber. A housing is configured for allowing insertion of the needle to a penetration depth. An energy source is configured for biasing the plunger to produce an injecting pressure in the medicament in the fluid chamber of between about 80 and 1000 p.s.i. to jet inject the medicament from the fluid chamber through the needle to an injection site.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: November 19, 2019
    Assignee: Antares Pharma, Inc.
    Inventor: Paul R. Lesch
  • Publication number: 20190217067
    Abstract: An inflation device includes a syringe body containing a bore. The bore holds a fluid that is used to inflate a separate device such as a dilation balloon. A plunger assembly slides within the syringe bore and contains a sealing member that forms a fluid tight seal with the syringe body. A shut-off valve is disposed within the distal end of the syringe body. The distal end of the syringe body has a fluid bypass channel fluidically coupled to the aperture of a connector. The shut-off valve has a spring-biased moveable piston with a bypass lumen contained therein, wherein the bypass lumen forms a fluid path between the bore and the fluid bypass channel when the pressure of the fluid is below a threshold value. The fluid path between the bore and the fluid bypass channel is interrupted when the pressure of the fluid is above the threshold value.
    Type: Application
    Filed: January 14, 2019
    Publication date: July 18, 2019
    Applicant: ENTELLUS MEDICAL, INC.
    Inventors: Paul R. Lesch, JR., Paul A. Vajgrt, Timothy B. Petrick
  • Patent number: 10201684
    Abstract: An inflation device includes a syringe body containing a bore. The bore holds a fluid that is used to inflate a separate device such as a dilation balloon. A plunger assembly slides within the syringe bore and contains a sealing member that forms a fluid tight seal with the syringe body. A shut-off valve is disposed within the distal end of the syringe body. The distal end of the syringe body has a fluid bypass channel fluidically coupled to the aperture of a connector. The shut-off valve has a spring-biased moveable piston with a bypass lumen contained therein, wherein the bypass lumen forms a fluid path between the bore and the fluid bypass channel when the pressure of the fluid is below a threshold value. The fluid path between the bore and the fluid bypass channel is interrupted when the pressure of the fluid is above the threshold value.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: February 12, 2019
    Assignee: ENTELLUS MEDICAL, INC.
    Inventors: Paul R. Lesch, Jr., Paul A. Vajgrt, Timothy B. Petrick
  • Publication number: 20180099099
    Abstract: A safety member for use with an injection device is disclosed. The safety member includes a blocking ring extending into a housing of the injection device in blocking association with a latch member associated with a trigger mechanism of the injector, in which the blocking ring blocks movement of a portion of the trigger mechanism into a firing position. The safety member further includes a manipulable portion disposed outside the housing and configured for hand-manipulation by a user to remove the safety member from the housing to unblock the firing mechanism to enable firing of the injector.
    Type: Application
    Filed: December 7, 2017
    Publication date: April 12, 2018
    Applicant: Antares Pharma, Inc.
    Inventors: Julius C. Sund, Eric Lagman, Peter Hoeft, Paul R. Lesch, JR., Thomas E. Kramer
  • Patent number: 9867949
    Abstract: A safety member for use with an injection device is disclosed. The safety member includes a blocking ring extending into a housing of the injection device in blocking association with a latch member associated with a trigger mechanism of the injector, in which the blocking ring blocks movement of a portion of the trigger mechanism into a firing position. The safety member further includes a manipulable portion disposed outside the housing and configured for hand-manipulation by a user to remove the safety member from the housing to unblock the firing mechanism to enable firing of the injector.
    Type: Grant
    Filed: July 23, 2014
    Date of Patent: January 16, 2018
    Assignee: Antares Pharma, Inc.
    Inventors: Julius C. Sund, Eric Lagman, Peter Hoeft, Paul R. Lesch, Jr., Thomas E. KraMer